Hot Line Presentation of Primary Results from ACACIA-HCM to Elaborate on Positive Topline Results in Patients with Non-Obstructive Hypertrophic Cardiomyopathy
COPENHAGEN, Denmark, August 20, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business update and announces second quarter 2026 financial results.
Jena, Germany, Aug. 20, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate in two investor conferences in September 2026. Details are as follows:
SAN DIEGO, August 20, 2026--Jack in the Box Inc. ("Jack in the Box" or the "Company") (NASDAQ: JACK), today announced its Board of Directors has appointed Taylor Montgomery as President, effective September 14, 2026. In this newly created role, Montgomery will lead Jack in the Box’s brand strategy, with a focus on driving sustainable sales growth, improving franchisee profitability, and positioning the Company for long-term success.
MONTREAL, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today the launch of WYNZORA ® , a uniform white aqueous cream containing 0.05 mg/g of calcipotriol (CAL) and 0.5 mg/g of betamethasone dipropionate (BDP), in Canada. WYNZORA ® is indicated for the topical treatment of psoriasis vulgaris in adults and adolescents aged 12 and older. 1
First registered, randomized Phase 3 trial evaluating the efficacy, safety, and tolerability of XIAFLEX in adults with hammer toe No FDA-approved nonsurgical therapies currently indicated for the treatment of hammer toe Hammer toe treatment today is limited to mainly orthotics,...
DODGEVILLE, Wis., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Lands' End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Thursday, September 3, 2026, to discuss its second quarter fiscal 2026 financial results.
SASKATOON, Saskatchewan, Aug. 20, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“ PharmaCorp ” or the “ Corporation ”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, today reported its financial results for the three and six months ended June 30, 2026.
ATLANTA, August 20, 2026--QumulusAI (Nasdaq: QMLS), a neocloud infrastructure provider purpose-built for the AI computing era, today announced a seven-year colocation agreement for up to 3.75 MW of data center capacity in metropolitan Atlanta, together with a right of first offer on as much as 7 MW of additional contiguous capacity at the same site. The contracted capacity is expected to support up to 2,048 NVIDIA Blackwell B300-class GPUs.
To Nasdaq Copenhagen and the Press
To Nasdaq Copenhagen and the Press
Til Nasdaq Copenhagen og pressen